Gsa Capital Partners LLP Selecta Biosciences Inc Transaction History

Gsa Capital Partners LLP

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 16, 2024	SELL	$0.67 - $1.35 $104,357 - $210,271	-155,757 Reduced 53.66%	134,501 $92,000
Q3 2023 Nov 15, 2023	BUY	$1.02 - $1.23 $296,063 - $357,017	290,258 New	290,258 $307,000
Q1 2023 May 12, 2023	SELL	$1.15 - $1.89 $45,265 - $74,392	-39,361 Reduced 10.58%	332,726 $462,000
Q4 2022 Feb 13, 2023	SELL	$0.96 - $1.6 $338,593 - $564,323	-352,702 Reduced 48.66%	372,087 $420,000
Q3 2022 Nov 14, 2022	SELL	$1.33 - $2.6 $96,095 - $187,855	-72,252 Reduced 9.07%	724,789 $1.19 Million
Q2 2022 Aug 09, 2022	BUY	$0.67 - $1.4 $432,517 - $903,767	645,548 Added 426.12%	797,041 $1.04 Million
Q1 2022 May 11, 2022	BUY	$1.23 - $3.31 $186,336 - $501,441	151,493 New	151,493 $186,000
Q1 2021 May 10, 2021	SELL	$2.92 - $5.07 $178,543 - $310,005	-61,145 Closed	0 $0
Q4 2020 Feb 03, 2021	BUY	$1.64 - $3.42 $100,277 - $209,115	61,145 New	61,145 $185,000
Q3 2019 Nov 12, 2019	SELL	$1.6 - $2.08 $133,542 - $173,605	-83,464 Closed	0 $0
Q2 2019 Aug 06, 2019	SELL	$1.79 - $3.05 $168,150 - $286,513	-93,939 Reduced 52.95%	83,464 $149,000
Q1 2019 May 15, 2019	BUY	$1.47 - $3.06 $260,782 - $542,853	177,403 New	177,403 $420,000

4.67M

Ticker SELB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 152,712,992
Market Cap $128M
Description
Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.